ICON plc

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

ICON was founded in Dublin, Ireland, by John Climax and Ronan Lambe in 1990. Since January 2010, Climax has held a position on the board of directors. Lambe retired from the board of directors in 2018.

Between 1991 and 1996, ICON opened offices in the United Kingdom, United States, and Japan. A year later, ICON shares started to be traded on Nasdaq.In 2018, ICON won the PharmaTimes Clinical Researcher of the Year. ICON received 2019 Clinical Research Organization leadership awards in five categories, determined by Life Science Leader magazine and Industry Standard Research .

In March 2017, Steve Cutler was appointed Chief Executive Officer of ICON. He had previously been with Quintiles South Africa, Sandoz AG, and Kendle Intl Inc, before joiníng ICON Clinical Research Services in 2011, and becoming Chief Operating Officer in 2014.